Top

Current Obesity Reports

Published in:

01-12-2020 | Obesity | Childhood Obesity (A Kelly and C Fox, Section Editor)

Weight Management in Youth with Type 1 Diabetes and Obesity: Challenges and Possible Solutions

Authors: Dessi P. Zaharieva, Ananta Addala, Kimber M. Simmons, David M. Maahs

Published in: Current Obesity Reports | Issue 4/2020

Abstract

Purpose of Review

This review highlights challenges associated with weight management in children and adolescents with type 1 diabetes (T1D). Our purpose is to propose potential solutions to improve weight outcomes in youth with T1D.

Recent Findings

A common barrier to weight management in T1D is reluctance to engage in exercise for fear of hypoglycemia. Healthcare practitioners generally provide limited guidance for insulin dosing and carbohydrate modifications to maintain stable glycemia during exercise. Adherence to dietary guidelines is associated with improved glycemia; however, youth struggle to meet recommendations. When psychosocial factors are addressed in combination with glucose trends, this often leads to successful T1D management. Newer medications also hold promise to potentially aid in glycemia and weight management, but further research is necessary.

Summary

Properly addressing physical activity, nutrition, pharmacotherapy, and psychosocial factors while emphasizing weight management may reduce the likelihood of obesity development and its perpetuation in this population.

Minges KE, Whittemore R, Grey M. Overweight and obesity in youth with type 1 diabetes. Annu Rev Nurs Res. 2013;31:47–69. https://doi.org/10.1891/0739-6686.31.47.CrossRefPubMedPubMedCentral

Minges KE, Whittemore R, Weinzimer SA, Irwin ML, Redeker NS, Grey M. Correlates of overweight and obesity in 5529 adolescents with type 1 diabetes: the T1D exchange clinic registry. Diabetes Res Clin Pract. 2017;126:68–78. https://doi.org/10.1016/j.diabres.2017.01.012.CrossRefPubMedPubMedCentral

Ogden CL, Carroll MD, Lawman HG, Fryar CD, Kruszon-Moran D, Kit BK, et al. Trends in obesity prevalence among children and adolescents in the United States, 1988-1994 through 2013-2014. JAMA. 2016;315:2292–9. https://doi.org/10.1001/jama.2016.6361.CrossRefPubMedPubMedCentral

Liu LL, Lawrence JM, Davis C, Liese AD, Pettitt DJ, Pihoker C, et al. Prevalence of overweight and obesity in youth with diabetes in USA: the search for diabetes in youth study. Pediatr Diabetes. 2010;11:4–11.CrossRefPubMed

Matheus AS, Tannus LR, Cobas RA, Palma CC, Negrato CA, Gomes MB. Impact of diabetes on cardiovascular disease: an update. Int J Hypertens. 2013;2013:653789. https://doi.org/10.1155/2013/653789.CrossRefPubMedPubMedCentral

Keeley TJH, Fox KR. The impact of physical activity and fitness on academic achievement and cognitive performance in children. Int J Sport Exerc Psychol. 1999;2:198–214.CrossRef

Kemper HC, Twisk JW, Koppes LL, Wv M, Post GB. A 15-year physical activity pattern is positively related to aerobic fitness in young males and females (13-27 years). Eur J Appl Physiol. 2001;84:395–402.CrossRefPubMed

Burrows M. Exercise and bone mineral accrual in children and adolescents. J Sports Sci Med. 2007;6:305–12.PubMedPubMedCentral

Baran J, Weres A, Czenczek-Lewandowska E, Wyszynska J, Luszczki E, Deren K, et al. Blood lipid profile and body composition in a pediatric population with different levels of physical activity. Lipids Health Dis. 2018;17:171. https://doi.org/10.1186/s12944-018-0817-2.CrossRefPubMedPubMedCentral

10.

Quirk H, Blake H, Tennyson R, Randell TL, Glazebrook C. Physical activity interventions in children and young people with type 1 diabetes mellitus: a systematic review with meta-analysis. Diabet Med. 2014;31:1163–73. https://doi.org/10.1111/dme.12531.CrossRefPubMedPubMedCentral

11.

MacMillan F, Kirk A, Mutrie N, Matthews L, Robertson K, Saunders DH. A systematic review of physical activity and sedentary behavior intervention studies in youth with type 1 diabetes: study characteristics, intervention design, and efficacy. Pediatr Diabetes. 2014;15:175–89. https://doi.org/10.1111/pedi.12060.CrossRefPubMed

12.

Pivovarov JA, Taplin CE, Riddell MC. Current perspectives on physical activity and exercise for youth with diabetes. Pediatr Diabetes. 2015;16:242–55. https://doi.org/10.1111/pedi.12272.CrossRefPubMed

13.

Andersen LB, Riddoch C, Kriemler S, Hills AP. Physical activity and cardiovascular risk factors in children. Br J Sports Med. 2011;45:871–6. https://doi.org/10.1136/bjsports-2011-090333.CrossRefPubMed

14.

Tarp J, Child A, White T, Westgate K, Bugge A, Grontved A, et al. Physical activity intensity, bout-duration, and cardiometabolic risk markers in children and adolescents. Int J Obes. 2018;42:1639–50. https://doi.org/10.1038/s41366-018-0152-8.CrossRef

15.

Herrmann SD, Angadi SS. Children’s physical activity and sedentary time and cardiometabolic risk factors. Clin J Sport Med. 2013;23:408–9. https://doi.org/10.1097/01.jsm.0000433154.58936.a8.CrossRefPubMed

16.

Fritz J, Coster ME, Nilsson JA, Rosengren BE, Dencker M, Karlsson MK. The associations of physical activity with fracture risk: a 7-year prospective controlled intervention study in 3534 children. Osteoporos Int. 2016;27:915–22. https://doi.org/10.1007/s00198-015-3311-y.CrossRefPubMed

17.

Detter F, Nilsson JA, Karlsson C, Dencker M, Rosengren BE, Karlsson MK. A 3-year school-based exercise intervention improves muscle strength - a prospective controlled population-based study in 223 children. BMC Musculoskelet Disord. 2014;15:353. https://doi.org/10.1186/1471-2474-15-353.CrossRefPubMedPubMedCentral

18.

Fritz J, Coster ME, Stenevi-Lundgren S, Nilsson JA, Dencker M, Rosengren BE, et al. A 5-year exercise program in children improves muscle strength without affecting fracture risk. Eur J Appl Physiol. 2016;116:707–15. https://doi.org/10.1007/s00421-015-3310-x.CrossRefPubMed

19.

Alvarez-Bueno C, Pesce C, Cavero-Redondo I, Sanchez-Lopez M, Martinez-Hortelano JA, Martinez-Vizcaino V. The effect of physical activity interventions on children’s cognition and metacognition: a systematic review and meta-analysis. J Am Acad Child Adolesc Psychiatry. 2017;56:729–38. https://doi.org/10.1016/j.jaac.2017.06.012.CrossRefPubMed

20.

Eime RM, Young JA, Harvey JT, Charity MJ, Payne WR. A systematic review of the psychological and social benefits of participation in sport for children and adolescents: informing development of a conceptual model of health through sport. Int J Behav Nutr Phys Act. 2013;10:98. https://doi.org/10.1186/1479-5868-10-98.CrossRefPubMedPubMedCentral

21.

Hagan JF, Shaw JS, PM D. Bright futures: guidelines for health supervision of infants, children, and adolescents. 4th ed: American Academy of Pediatrics; 2017.

22.

Zhang Y, Zhang H, Li P. Cardiovascular risk factors in children with type 1 diabetes mellitus. J Pediatr Endocrinol Metab. 2019;32:699–705. https://doi.org/10.1515/jpem-2018-0382.CrossRefPubMed

23.

Gunczler P, Lanes R, Paz-Martinez V, Martins R, Esaa S, Colmenares V, et al. Decreased lumbar spine bone mass and low bone turnover in children and adolescents with insulin dependent diabetes mellitus followed longitudinally. J Pediatr Endocrinol Metab. 1998;11:413–9. https://doi.org/10.1515/jpem.1998.11.3.413.CrossRefPubMed

24.

Pan H, Wu N, Yang T, He W. Association between bone mineral density and type 1 diabetes mellitus: a meta-analysis of cross-sectional studies. Diabetes Metab Res Rev. 2014;30:531–42. https://doi.org/10.1002/dmrr.2508.CrossRefPubMed

25.

Buchberger B, Huppertz H, Krabbe L, Lux B, Mattivi JT, Siafarikas A. Symptoms of depression and anxiety in youth with type 1 diabetes: a systematic review and meta-analysis. Psychoneuroendocrinology. 2016;70:70–84. https://doi.org/10.1016/j.psyneuen.2016.04.019.CrossRefPubMed

26.

Caruso NC, Radovanovic B, Kennedy JD, Couper J, Kohler M, Kavanagh PS, et al. Sleep, executive functioning and behaviour in children and adolescents with type 1 diabetes. Sleep Med. 2014;15:1490–9. https://doi.org/10.1016/j.sleep.2014.08.011.CrossRefPubMed

27.

Vaisto J, Eloranta AM, Viitasalo A, Tompuri T, Lintu N, Karjalainen P, et al. Physical activity and sedentary behaviour in relation to cardiometabolic risk in children: cross-sectional findings from the physical activity and nutrition in children (panic) study. Int J Behav Nutr Phys Act. 2014;11:55. https://doi.org/10.1186/1479-5868-11-55.CrossRefPubMedPubMedCentral

28.

The Physical Activity Guidelines Advisory Committee. 2018 Physical activity guidelines advisory committee scientific report. Washington, DC: Department of Health and Human Services; 2018.

29.

Juonala M, Viikari JS, Kahonen M, Taittonen L, Laitinen T, Hutri-Kahonen N, et al. Life-time risk factors and progression of carotid atherosclerosis in young adults: the cardiovascular risk in young finns study. Eur Heart J. 2010;31:1745–51. https://doi.org/10.1093/eurheartj/ehq141.CrossRefPubMed

30.

Ried-Larsen M, Grontved A, Kristensen PL, Froberg K, Andersen LB. Moderate-and-vigorous physical activity from adolescence to adulthood and subclinical atherosclerosis in adulthood: prospective observations from the European Youth Heart Study. Br J Sports Med. 2015;49:107–12. https://doi.org/10.1136/bjsports-2013-092409.CrossRefPubMed

31.

Maggio AB, Rizzoli RR, Marchand LM, Ferrari S, Beghetti M, Farpour-Lambert NJ. Physical activity increases bone mineral density in children with type 1 diabetes. Med Sci Sports Exerc. 2012;44:1206–11.CrossRefPubMed

32.

Korczak DJ, Madigan S, Colasanto M. Children’s physical activity and depression: a meta-analysis. Pediatrics. 2017;139. https://doi.org/10.1542/peds.2016-2266.

33.

Van Dusen DP, Kelder SH, Kohl HW 3rd, Ranjit N, Perry CL. Associations of physical fitness and academic performance among schoolchildren. J Sch Health. 2011;81:733–40. https://doi.org/10.1111/j.1746-1561.2011.00652.x.CrossRefPubMed

34.

Karlsson M, Rosengren B. Physical activity and academic achievements. Acta Paediatr. 2020;109:14–6. https://doi.org/10.1111/apa.15052.CrossRefPubMed

35.

Korhonen T, Kujala UM, Rose RJ, Kaprio J. Physical activity in adolescence as a predictor of alcohol and illicit drug use in early adulthood: a longitudinal population-based twin study. Twin Res Hum Genet. 2009;12:261–8. https://doi.org/10.1375/twin.12.3.261.CrossRefPubMedPubMedCentral

36.

Ali MM, Amialchuk A, Heller LR. The influence of physical activity on cigarette smoking among adolescents: evidence from add health. Nicotine Tob Res. 2015;17:539–45. https://doi.org/10.1093/ntr/ntu171.CrossRefPubMed

37.

Corbin KD, Driscoll KA, Pratley RE, Smith SR, Maahs DM, Mayer-Davis EJ, et al. Obesity in type 1 diabetes: pathophysiology, clinical impact, and mechanisms. Endocr Rev. 2018;39:629–63. https://doi.org/10.1210/er.2017-00191.CrossRefPubMed

38.

Zaharieva DP, Messer L, Paldus B, O’Neal DN, Maahs D, Riddell MC. Glucose control during physical activity and exercise using closed loop technology in type 1 diabetes. Can J Diabetes. 2020; https://doi.org/10.1016/j.jcjd.2020.06.003.

39.

Driscoll KA, Raymond J, Naranjo D, Patton SR. Fear of hypoglycemia in children and adolescents and their parents with type 1 diabetes. Curr Diab Rep. 2016;16:77. https://doi.org/10.1007/s11892-016-0762-2.CrossRefPubMedPubMedCentral

40.

Adolfsson P, Riddell MC, Taplin CE, Davis EA, Fournier PA, Annan F, et al. Ispad clinical practice consensus guidelines 2018: Exercise in children and adolescents with diabetes. Pediatr Diabetes. 2018;19(Suppl 27):205–26. https://doi.org/10.1111/pedi.12755.CrossRefPubMed

41.

American Diabetes Association. 13. Children and adolescents: standards of medical care in diabetes-2020. Diabetes Care. 2020;43:S163–82. https://doi.org/10.2337/dc20-S013.CrossRef

42.

Kahkoska AR, Watts ME, Driscoll KA, Bishop FK, Mihas P, Thomas J, et al. Understanding antagonism and synergism: a qualitative assessment of weight management in youth with type 1 diabetes mellitus. Obes Med. 2018;9:21–31. https://doi.org/10.1016/j.obmed.2017.12.001.CrossRefPubMedPubMedCentral

43.

Addala A, Igudesman D, Kahkoska AR, Muntis FR, Souris KJ, Whitaker KJ, et al. The interplay of type 1 diabetes and weight management: a qualitative study exploring thematic progression from adolescence to young adulthood. Pediatr Diabetes. 2019;20:974–85. https://doi.org/10.1111/pedi.12903.CrossRefPubMedPubMedCentral

44.

Kumar S, Kelly AS. Review of childhood obesity: from epidemiology, etiology, and comorbidities to clinical assessment and treatment. Mayo Clin Proc. 2017;92:251–65. https://doi.org/10.1016/j.mayocp.2016.09.017.CrossRefPubMed

45.

Rajjo T, Mohammed K, Alsawas M, Ahmed AT, Farah W, Asi N, et al. Treatment of pediatric obesity: an umbrella systematic review. J Clin Endocrinol Metab. 2017;102:763–75. https://doi.org/10.1210/jc.2016-2574.CrossRefPubMed

46.

Driscoll KA, Corbin KD, Maahs DM, Pratley R, Bishop FK, Kahkoska A, et al. Biopsychosocial aspects of weight management in type 1 diabetes: a review and next steps. Curr Diab Rep. 2017;17:58. https://doi.org/10.1007/s11892-017-0892-1.CrossRefPubMedPubMedCentral

47.

Forney KJ, Buchman-Schmitt JM, Keel PK, Frank GK. The medical complications associated with purging. Int J Eat Disord. 2016;49:249–59. https://doi.org/10.1002/eat.22504.CrossRefPubMedPubMedCentral

48.

Bulbul S. Exercise in the treatment of childhood obesity. Turk Pediatri Ars. 2020;55:2–10. https://doi.org/10.14744/TurkPediatriArs.2019.60430.CrossRefPubMedPubMedCentral

49.

Xu F, Marchand S, Corcoran C, DiBiasio H, Clough R, Dyer CS, et al. A community-based nutrition and physical activity intervention for children who are overweight or obese and their caregivers. J Obes. 2017;2017:2746595. https://doi.org/10.1155/2017/2746595.CrossRefPubMedPubMedCentral

50.

Ho M, Garnett SP, Baur LA, Burrows T, Stewart L, Neve M, et al. Impact of dietary and exercise interventions on weight change and metabolic outcomes in obese children and adolescents: a systematic review and meta-analysis of randomized trials. JAMA Pediatr. 2013;167:759–68. https://doi.org/10.1001/jamapediatrics.2013.1453.CrossRefPubMed

51.

Guthold R, Stevens GA, Riley LM, Bull FC. Global trends in insufficient physical activity among adolescents: a pooled analysis of 298 population-based surveys with 1.6 million participants. Lancet Child Adolesc Health. 2020;4:23–35. https://doi.org/10.1016/S2352-464219)30323-2.CrossRefPubMedPubMedCentral

52.

Sundberg F, Forsander G, Fasth A, Ekelund U. Children younger than 7 years with type 1 diabetes are less physically active than healthy controls. Acta Paediatr. 2012;101:1164–9. https://doi.org/10.1111/j.1651-2227.2012.02803.x.CrossRefPubMed

53.

Czenczek-Lewandowska E, Leszczak J, Weres A, Baran J, Wyszynska J, Grzegorczyk J, et al. Sedentary behaviors in children and adolescents with type 1 diabetes, depending on the insulin therapy used. Medicine (Baltimore). 2019;98:e15625. https://doi.org/10.1097/MD.0000000000015625.CrossRef

54.

Kummer S, Stahl-Pehe A, Castillo K, Bachle C, Graf C, Strassburger K, et al. Health behaviour in children and adolescents with type 1 diabetes compared to a representative reference population. PLoS One. 2014;9:e112083. https://doi.org/10.1371/journal.pone.0112083.CrossRefPubMedPubMedCentral

55.

Fintini D, Di Giacinto B, Brufani C, Cafiero G, Patera PI, Turchetta A, et al. Impaired energy expenditure despite normal cardiovascular capacity in children with type 1 diabetes. Horm Res Paediatr. 2012;78:1–7. https://doi.org/10.1159/000339465.CrossRefPubMed

56.

Riddell MC, Perkins BA. Type 1 diabetes and vigorous exercise: applications of exercise physiology to patient management. Can J Diabetes. 2006;30:63–71. https://doi.org/10.1016/S1499-2671(06)01010-0.

57.

Yardley JE, Kenny GP, Perkins BA, Riddell MC, Malcolm J, Boulay P, et al. Effects of performing resistance exercise before versus after aerobic exercise on glycemia in type 1 diabetes. Diabetes Care. 2012;35:669–75. https://doi.org/10.2337/dc11-1844.CrossRefPubMedPubMedCentral

58.

Chetty T, Shetty V, Fournier PA, Adolfsson P, Jones TW, Davis EA. Exercise management for young people with type 1 diabetes: a structured approach to the exercise consultation. Front Endocrinol (Lausanne). 2019;10:326. https://doi.org/10.3389/fendo.2019.00326.CrossRef

59.

Hill JO, Wyatt HR, Peters JC. The importance of energy balance. Eur Endocrinol. 2013;9:111–5. https://doi.org/10.17925/EE.2013.09.02.111.CrossRefPubMedPubMedCentral

60.

McAuley SA, Horsburgh JC, Ward GM, La Gerche A, Gooley JL, Jenkins AJ, et al. Insulin pump basal adjustment for exercise in type 1 diabetes: a randomised crossover study. Diabetologia. 2016;59:1636–44. https://doi.org/10.1007/s00125-016-3981-9.CrossRefPubMed

61.

Zaharieva D, McGaugh S, Pooni R, Vienneau T, Ly T, Riddell M. Improved open-loop glucose control with basal insulin reduction 90 minutes before aerobic exercise in patients with type 1 diabetes on continuous subcutaneous insulin infusion. Diabetes Care. 2019;42:824–31.CrossRefPubMed

62.

Neyman A, Woerner S, Russ M, Yarbrough A, DiMeglio LA. Strategies that adolescents with type 1 diabetes use in relation to exercise. Clin Diabetes. 2020; https://doi.org/10.2337/cd19-0196.

63.

Moser O, Eckstein ML, West DJ, Goswami N, Sourij H, Hofmann P. Type 1 diabetes and physical exercise: moving (forward) as an adjuvant therapy. Curr Pharm Des. 2020. https://doi.org/10.2174/1381612826666200108113002.

64.

Scott SN, Anderson L, Morton JP, Wagenmakers AJM, Riddell MC. Carbohydrate restriction in type 1 diabetes: a realistic therapy for improved glycaemic control and athletic performance? Nutrients. 2019;11. https://doi.org/10.3390/nu11051022.

65.

Maran A, Pavan P, Bonsembiante B, Brugin E, Ermolao A, Avogaro A, et al. Continuous glucose monitoring reveals delayed nocturnal hypoglycemia after intermittent high-intensity exercise in nontrained patients with type 1 diabetes. Diabetes Technol Ther. 2010;12:763–8. https://doi.org/10.1089/dia.2010.0038.CrossRefPubMed

66.

Riddell MC, Gallen IW, Smart CE, Taplin CE, Adolfsson P, Lumb AN, et al. Exercise management in type 1 diabetes: a consensus statement. Lancet Diabetes Endocrinol. 2017;5:377–90. https://doi.org/10.1016/S2213-8587(17)30014-1.CrossRefPubMed

67.

Taplin CE, Cobry E, Messer L, McFann K, Chase HP, Fiallo-Scharer R. Preventing post-exercise nocturnal hypoglycemia in children with type 1 diabetes. J Pediatr. 2010;157:784–8. https://doi.org/10.1016/j.jpeds.2010.06.004.CrossRefPubMedPubMedCentral

68.

Geddes J, Schopman JE, Zammitt NN, Frier BM. Prevalence of impaired awareness of hypoglycaemia in adults with type 1 diabetes. Diabet Med. 2008;25:501–4. https://doi.org/10.1111/j.1464-5491.2008.02413.x.CrossRefPubMed

69.

Farrell CM, McNeilly AD, Fournier P, Jones T, Hapca SM, West D, et al. A randomised controlled study of high intensity exercise as a dishabituating stimulus to improve hypoglycaemia awareness in people with type 1 diabetes: a proof-of-concept study. Diabetologia. 2020;63:853–63. https://doi.org/10.1007/s00125-019-05076-5.CrossRefPubMedPubMedCentral

70.

Brickwood KJ, Watson G, O’Brien J, Williams AD. Consumer-based wearable activity trackers increase physical activity participation: systematic review and meta-analysis. JMIR Mhealth Uhealth. 2019;7:e11819. https://doi.org/10.2196/11819.CrossRefPubMedPubMedCentral

71.

Bohm B, Karwiese SD, Bohm H, Oberhoffer R. Effects of mobile health including wearable activity trackers to increase physical activity outcomes among healthy children and adolescents: systematic review. JMIR Mhealth Uhealth. 2019;7:e8298. https://doi.org/10.2196/mhealth.8298.CrossRefPubMedPubMedCentral

72.

Maahs DM, Horton LA, Chase HP. The use of insulin pumps in youth with type 1 diabetes. Diabetes Technol Ther. 2010;12(Suppl 1):S59–65.CrossRefPubMed

73.

Johnson SR, Cooper MN, Jones TW, Davis EA. Long-term outcome of insulin pump therapy in children with type 1 diabetes assessed in a large population-based case-control study. Diabetologia. 2013;56:2392–400. https://doi.org/10.1007/s00125-013-3007-9.CrossRefPubMed

74.

Danne T, Nimri R, Battelino T, Bergenstal RM, Close KL, DeVries JH, et al. International consensus on use of continuous glucose monitoring. Diabetes Care. 2017;40:1631–40. https://doi.org/10.2337/dc17-1600.CrossRefPubMedPubMedCentral

75.

American Diabetes Association. 7. Diabetes technology: standards of medical care in diabetes-2020. Diabetes Care. 2020;43:S77–88. https://doi.org/10.2337/dc20-S007.CrossRef

76.

Battelino T, Conget I, Olsen B, Schütz-Fuhrmann I, Hommel E, Hoogma R, et al. The use and efficacy of continuous glucose monitoring in type 1 diabetes treated with insulin pump therapy: a randomised controlled trial. Diabetologia. 2012;55:3155–62. https://doi.org/10.1007/s00125-012-2708-9.CrossRefPubMedPubMedCentral

77.

Juvenile Diabetes Research Foundation Continuous Glucose Monitoring Study Group. Effectiveness of continuous glucose monitoring in a clinical care environment: evidence from the juvenile diabetes research foundation continuous glucose monitoring (JDRF-CGM) trial. Diabetes Care. 2010;33:17–22. https://doi.org/10.2337/dc09-1502.CrossRef

78.

Riveline JP, Schaepelynck P, Chaillous L, Renard E, Sola-Gazagnes A, Penfornis A, et al. Assessment of patient-led or physician-driven continuous glucose monitoring in patients with poorly controlled type 1 diabetes using basal-bolus insulin regimens: a 1-year multicenter study. Diabetes Care. 2012;35:965–71. https://doi.org/10.2337/dc11-2021.CrossRefPubMedPubMedCentral

79.

Wong JC, Foster NC, Maahs DM, Raghinaru D, Bergenstal RM, Ahmann AJ, et al. Real-time continuous glucose monitoring among participants in the T1D exchange clinic registry. Diabetes Care. 2014;37:2702–9. https://doi.org/10.2337/dc14-0303.CrossRefPubMedPubMedCentral

80.

Prahalad P, Addala A, Scheinker D, Hood KK, Maahs DM. CGM initiation soon after type 1 diabetes diagnosis results in sustained CGM use and wear time. Diabetes Care. 2020;43:e3–4. https://doi.org/10.2337/dc19-1205.CrossRefPubMed

81.

Ekhlaspour L, Forlenza GP, Chernavvsky D, Maahs DM, Wadwa RP, Deboer MD, et al. Closed loop control in adolescents and children during winter sports: use of the tandem control-iq ap system. Pediatr Diabetes. 2019;20:759–68. https://doi.org/10.1111/pedi.12867.CrossRefPubMedPubMedCentral

82.

Dovc K, Macedoni M, Bratina N, Lepej D, Nimri R, Atlas E, et al. Closed-loop glucose control in young people with type 1 diabetes during and after unannounced physical activity: a randomised controlled crossover trial. Diabetologia. 2017;60:2157–67. https://doi.org/10.1007/s00125-017-4395-z.CrossRefPubMedPubMedCentral

83.

Breton MD, Chernavvsky DR, Forlenza GP, DeBoer MD, Robic J, Wadwa RP, et al. Closed-loop control during intense prolonged outdoor exercise in adolescents with type 1 diabetes: the artificial pancreas ski study. Diabetes Care. 2017;40:1644–50. https://doi.org/10.2337/dc17-0883.CrossRefPubMedPubMedCentral

84.

Garg SK, Weinzimer SA, Tamborlane WV, Buckingham BA, Bode BW, Bailey TS, et al. Glucose outcomes with the in-home use of a hybrid closed-loop insulin delivery system in adolescents and adults with type 1 diabetes. Diabetes Technol Ther. 2017;19:155–63. https://doi.org/10.1089/dia.2016.0421.CrossRefPubMedPubMedCentral

85.

Shai I, Schwarzfuchs D, Henkin Y, Shahar DR, Witkow S, Greenberg I, et al. Weight loss with a low-carbohydrate, Mediterranean, or low-fat diet. N Engl J Med. 2008;359:229–41. https://doi.org/10.1056/NEJMoa0708681.CrossRefPubMed

86.

Estruch R, Ros E, Salas-Salvado J, Covas MI, Corella D, Aros F, et al. Primary prevention of cardiovascular disease with a Mediterranean diet. N Engl J Med. 2013;368:1279–90. https://doi.org/10.1056/NEJMoa1200303.CrossRefPubMed

87.

Smart CE, Annan F, Higgins LA, Jelleryd E, Lopez M, Acerini CL. ISPAD clinical practice consensus guidelines 2018: Nutritional management in children and adolescents with diabetes. Pediatr Diabetes. 2018;19(Suppl 27):136–54. https://doi.org/10.1111/pedi.12738.CrossRefPubMed

88.

Patton SR, Dolan LM, Powers SW. Dietary adherence and associated glycemic control in families of young children with type 1 diabetes. J Am Diet Assoc. 2007;107:46–52. https://doi.org/10.1016/j.jada.2006.10.012.CrossRefPubMed

89.

Patton SR. Adherence to diet in youth with type 1 diabetes. J Am Diet Assoc. 2011;111:550–5. https://doi.org/10.1016/j.jada.2011.01.016.CrossRefPubMedPubMedCentral

90.

Faber EM, van Kampen PM, Clement-de Boers A, Houdijk E, van der Kaay DCM. The influence of food order on postprandial glucose levels in children with type 1 diabetes. Pediatr Diabetes. 2018;19:809–15. https://doi.org/10.1111/pedi.12640.CrossRefPubMed

91.

Bolla AM, Caretto A, Laurenzi A, Scavini M, Piemonti L. Low-carb and ketogenic diets in type 1 and type 2 diabetes. Nutrients. 2019;11. https://doi.org/10.3390/nu11050962.

92.

Krebs JD, Parry Strong A, Cresswell P, Reynolds AN, Hanna A, Haeusler S. A randomised trial of the feasibility of a low carbohydrate diet vs standard carbohydrate counting in adults with type 1 diabetes taking body weight into account. Asia Pac J Clin Nutr. 2016;25:78–84. https://doi.org/10.6133/apjcn.2016.25.1.11.CrossRefPubMed

93.

Eiswirth M, Clark E, Diamond M. Low carbohydrate diet and improved glycaemic control in a patient with type one diabetes. Endocrinol Diabetes Metab Case Rep. 2018;2018:18–0002. https://doi.org/10.1530/EDM-18-0002.CrossRefPubMedPubMedCentral

94.

Leow ZZX, Guelfi KJ, Davis EA, Jones TW, Fournier PA. The glycaemic benefits of a very-low-carbohydrate ketogenic diet in adults with type 1 diabetes mellitus may be opposed by increased hypoglycaemia risk and dyslipidaemia. Diabet Med. 2018. https://doi.org/10.1111/dme.13663.

95.

de Bock M, Lobley K, Anderson D, Davis E, Donaghue K, Pappas M, et al. Endocrine and metabolic consequences due to restrictive carbohydrate diets in children with type 1 diabetes: an illustrative case series. Pediatr Diabetes. 2018;19:129–37. https://doi.org/10.1111/pedi.12527.CrossRefPubMed

96.

Lennerz BS, Barton A, Bernstein RK, Dikeman RD, Diulus C, Hallberg S, et al. Management of type 1 diabetes with a very low-carbohydrate diet. Pediatrics. 2018;141. https://doi.org/10.1542/peds.2017-3349.

97.

Ranjan A, Schmidt S, Damm-Frydenberg C, Steineck I, Clausen TR, Holst JJ, et al. Low-carbohydrate diet impairs the effect of glucagon in the treatment of insulin-induced mild hypoglycemia: a randomized crossover study. Diabetes Care. 2017;40:132–5. https://doi.org/10.2337/dc16-1472.CrossRefPubMed

98.

Chen TY, Smith W, Rosenstock JL, Lessnau KD. A life-threatening complication of Atkins diet. Lancet. 2006;367:958. https://doi.org/10.1016/S0140-6736(06)68394-3.CrossRefPubMed

99.

Chalasani S, Fischer J. South beach diet associated ketoacidosis: a case report. J Med Case Rep. 2008;2:45. https://doi.org/10.1186/1752-1947-2-45.CrossRefPubMedPubMedCentral

100.

Styne DM, Arslanian SA, Connor EL, Farooqi IS, Murad MH, Silverstein JH, et al. Pediatric obesity-assessment, treatment, and prevention: an endocrine society clinical practice guideline. J Clin Endocrinol Metab. 2017;102:709–57. https://doi.org/10.1210/jc.2016-2573.CrossRefPubMedPubMedCentral

101.

American Diabetes Association. Chapter 5: facilitating behavior change and well-being to improve health outcomes: standards of medical care in diabetes-2020. Diabetes Care. 2020;43:S48–65. https://doi.org/10.2337/dc20-S005.CrossRef

102.

Delamater AM, de Wit M, McDarby V, Malik JA, Hilliard ME, Northam E, et al. Ispad clinical practice consensus guidelines 2018: Psychological care of children and adolescents with type 1 diabetes. Pediatr Diabetes. 2018;19(Suppl 27):237–49. https://doi.org/10.1111/pedi.12736.CrossRefPubMed

103.

Wild D, von Maltzahn R, Brohan E, Christensen T, Clauson P, Gonder-Frederick L. A critical review of the literature on fear of hypoglycemia in diabetes: implications for diabetes management and patient education. Patient Educ Couns. 2007;68:10–5. https://doi.org/10.1016/j.pec.2007.05.003.CrossRefPubMed

104.

Muller L, Habif S, Leas S, Aronoff-Spencer E. Reducing hypoglycemia in the real world: a retrospective analysis of predictive low-glucose suspend technology in an ambulatory insulin-dependent cohort. Diabetes Technol Ther. 2019;21:478–84. https://doi.org/10.1089/dia.2019.0190.CrossRefPubMedPubMedCentral

105.

Sherr JL, Tauschmann M, Battelino T, de Bock M, Forlenza G, Roman R, et al. ISPAD clinical practice consensus guidelines 2018: Diabetes technologies. Pediatr Diabetes. 2018;19(Suppl 27):302–25. https://doi.org/10.1111/pedi.12731.CrossRefPubMed

106.

Diabetes Control and Complications Trial Research Group, Nathan DM, Genuth S, Lachin J, Cleary P, et al. The effect of intensive treatment of diabetes on the development and progression of long-term complications in insulin-dependent diabetes mellitus. N Engl J Med. 1993;329:977–86. https://doi.org/10.1056/NEJM199309303291401.CrossRef

107.

Diabetes Control and Complications Trial/Epidemiology of Diabetes Interventions and Complications Study Research Group. Intensive diabetes treatment and cardiovascular outcomes in type 1 diabetes: the DCCT/EDIC study 30-year follow-up. Diabetes Care. 2016;39:686–93. https://doi.org/10.2337/dc15-1990.CrossRef

108.

Matteucci E, Giampietro O, Covolan V, Giustarini D, Fanti P, Rossi R. Insulin administration: present strategies and future directions for a noninvasive (possibly more physiological) delivery. Drug Des Devel Ther. 2015;9:3109–18. https://doi.org/10.2147/DDDT.S79322.CrossRefPubMedPubMedCentral

109.

Edgerton DS, Lautz M, Scott M, Everett CA, Stettler KM, Neal DW, et al. Insulin’s direct effects on the liver dominate the control of hepatic glucose production. J Clin Invest. 2006;116:521–7. https://doi.org/10.1172/JCI27073.CrossRefPubMedPubMedCentral

110.

Taylor SI, Blau JE, Rother KI, Beitelshees AL. SGLT2 inhibitors as adjunctive therapy for type 1 diabetes: balancing benefits and risks. Lancet Diabetes Endocrinol. 2019;7:949–58. https://doi.org/10.1016/S2213-8587(19)30154-8.CrossRefPubMedPubMedCentral

111.

Cherney DZ, Perkins BA. Sodium-glucose cotransporter 2 inhibition in type 1 diabetes: simultaneous glucose lowering and renal protection? Can J Diabetes. 2014;38:356–63. https://doi.org/10.1016/j.jcjd.2014.05.006.CrossRefPubMed

112.

Garg SK, Henry RR, Banks P, Buse JB, Davies MJ, Fulcher GR, et al. Effects of sotagliflozin added to insulin in patients with type 1 diabetes. N Engl J Med. 2017;377:2337–48. https://doi.org/10.1056/NEJMoa1708337.CrossRefPubMed

113.

Biester T, Aschemeier B, Fath M, Frey M, Scheerer MF, Kordonouri O, et al. Effects of dapagliflozin on insulin-requirement, glucose excretion and ss-hydroxybutyrate levels are not related to baseline hba1c in youth with type 1 diabetes. Diabetes Obes Metab. 2017;19:1635–9. https://doi.org/10.1111/dom.12975.CrossRefPubMed

114.

Biester T, Nieswandt A, Biester S, Remus K, Muller I, Atlas E, et al. Adjunctive therapy with dapagliflozin improves full closed loop post prandial glycaemic control in type 1 diabetic young adults - The DAPADream. International Diabetes Federation 2017 Congress. 2017: Abu Dhabi.

115.

Polsky S, Ellis SL. Obesity, insulin resistance, and type 1 diabetes mellitus. Curr Opin Endocrinol Diabetes Obes. 2015;22:277–82. https://doi.org/10.1097/MED.0000000000000170.CrossRefPubMed

116.

Hinnen D. Glucagon-like peptide 1 receptor agonists for type 2 diabetes. Diabetes Spectr. 2017;30:202–10. https://doi.org/10.2337/ds16-0026.CrossRefPubMedPubMedCentral

117.

Pi-Sunyer X, Astrup A, Fujioka K, Greenway F, Halpern A, Krempf M, et al. A randomized, controlled trial of 3.0 mg of liraglutide in weight management. N Engl J Med. 2015;373:11–22. https://doi.org/10.1056/NEJMoa1411892.CrossRefPubMed

118.

Traina AN, Lull ME, Hui AC, Zahorian TM, Lyons-Patterson J. Once-weekly exenatide as adjunct treatment of type 1 diabetes mellitus in patients receiving continuous subcutaneous insulin infusion therapy. Can J Diabetes. 2014;38:269–72. https://doi.org/10.1016/j.jcjd.2013.10.006.CrossRefPubMed

119.

Raman VS, Mason KJ, Rodriguez LM, Hassan K, Yu X, Bomgaars L, et al. The role of adjunctive exenatide therapy in pediatric type 1 diabetes. Diabetes Care. 2010;33:1294–6. https://doi.org/10.2337/dc09-1959.CrossRefPubMedPubMedCentral

120.

Liu L, Shao Z, Xia Y, Qin J, Xiao Y, Zhou Z, et al. Incretin-based therapies for patients with type 1 diabetes: a meta-analysis. Endocr Connect. 2019;8:277–88. https://doi.org/10.1530/EC-18-0546.CrossRefPubMedPubMedCentral

121.

Marlow AL, Rowe CW, Anderson D, Wynne K, King BR, Howley P, et al. Young children, adolescent girls and women with type 1 diabetes are more overweight and obese than reference populations, and this is associated with increased cardiovascular risk factors. Diabet Med. 2019;36:1487–93. https://doi.org/10.1111/dme.14133.CrossRefPubMed

Title: Weight Management in Youth with Type 1 Diabetes and Obesity: Challenges and Possible Solutions
Authors: Dessi P. Zaharieva
Ananta Addala
Kimber M. Simmons
David M. Maahs
Publication date: 01-12-2020
Publisher: Springer US
Keywords: Obesity
Obesity
Insulins
Hypoglycemia
Insulins
Type 1 Diabetes
Published in: Current Obesity Reports / Issue 4/2020
Electronic ISSN: 2162-4968
DOI: https://doi.org/10.1007/s13679-020-00411-z

Live Webinar | 27-06-2024 | 18:00 (CEST)

Keynote webinar | Spotlight on medication adherence

Reserve your place

Live: Thursday 27th June 2024, 18:00-19:30 (CEST)

WHO estimates that half of all patients worldwide are non-adherent to their prescribed medication. The consequences of poor adherence can be catastrophic, on both the individual and population level.

Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.

Prof. Kevin Dolgin

Prof. Florian Limbourg

Prof. Anoop Chauhan

Developed by: Springer Medicine

Obesity Clinical Trial Summary

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine

Highlights from the ACC 2024 Congress

Year in Review: Pediatric cardiology

Pediatric Cardiology Video

Watch Dr. Anne Marie Valente present the last year's highlights in pediatric and congenital heart disease in the official ACC.24 Year in Review session.

Year in Review: Pulmonary vascular disease

Cardiopulmonary Comorbidity Video

The last year's highlights in pulmonary vascular disease are presented by Dr. Jane Leopold in this official video from ACC.24.

Year in Review: Valvular heart disease

Valvular Heart Disease Video

Watch Prof. William Zoghbi present the last year's highlights in valvular heart disease from the official ACC.24 Year in Review session.

Year in Review: Heart failure and cardiomyopathies

Heart Failure Video

Watch this official video from ACC.24. Dr. Biykem Bozkurt discusses last year's major advances in heart failure and cardiomyopathies.

ACC 2024 Congress Coverage

Year in Review: Heart failure and cardiomyopathies

Heart Failure Video

Watch this official video from ACC.24. Dr. Biykem Bozkurt discusses last year's major advances in heart failure and cardiomyopathies.

Watch now

Semaglutide benefits people with type 2 diabetes and obesity-related heart failure

16-04-2024 Type 2 Diabetes News

Incentivised to exercise

11-04-2024 Lifestyle Modifications News

New intervention for STEMI-related cardiogenic shock

10-04-2024 Myocardial Infarction News

» View more highlights on the ACC 2024 congress hub page

Image Credits

Illustration of figure on mountain summit/© Orapun / Stock.adobe.com, STEP AAG HeroTeaserCollection image/© Tarek / Generated with AI / Stock.adobe.com, ACC 2024 Pediatric and Congenital Heart Disease: Year in Review/© 2024 American College of Cardiology, ACC 2024 Pulmonary Vascular Disease: Year in Review/© 2024 American College of Cardiology, ACC 2024 Valvular Heart Disease: Year in Review/© 2024 American College of Cardiology, ACC 2024 HF and Cardiomyopathies: Year in Review/© 2024 American College of Cardiology, Woman out walking/© Seventyfour / stock.adobe.com (symbolic image with model), Woman checking smartwatch /© saltdium / stock.adobe.com (symbolic image with model), Cardiac catheterization/© Damian / stock.adobe.com

Keynote webinar | Spotlight on medication adherence

Springer Medicine

Abstract

Purpose of Review

Recent Findings

Summary

Please log in to get access to this content

Other articles of this Issue 4/2020

The Co-occurrence of Pediatric Obesity and ADHD: an Understanding of Shared Pathophysiology and Implications for Collaborative Management

The Role of Eating Behaviours in Genetic Susceptibility to Obesity

Socioeconomic Status and Childhood Obesity: a Review of Literature from the Past Decade to Inform Intervention Research

Measuring Food Culture: a Tool for Public Health Practice

Role of GLP-1 Receptor Agonists in Pediatric Obesity: Benefits, Risks, and Approaches to Patient Selection

Correction to: Obesity: a Ghost at the Feast of the Sustainable Development Goals

Live: Thursday 27th June 2024, 18:00-19:30 (CEST)

Highlights from the ACC 2024 Congress

ACC 2024 Congress Coverage